Accumulating studies suggest that IGF2-IGF1R signaling is critical for cell proliferation, differentiation, EMT, migration, stemness maintenance, and drug resistance in multiple malignancies, including HCC 18, 19. The gene discussed is IGF2; the disease is hepatocellular carcinoma.